声共振疗法治疗鼻炎鼻塞安全有效:一项随机假对照试验
这项多中心、随机、双盲、假对照干预研究纳入52例成人鼻炎患者,评估振动头带实施声共振疗法(ART)每日两次、持续2周的疗效。结果显示ART较假治疗显著改善鼻塞亚评分和复合鼻部症状总分,应答率80.8%对46.2%,调整风险比1.95,未见不良事件。
要点
- ART组鼻塞亚评分平均变化-0.87,假治疗组-0.44,组间差异有统计学意义(p=0.008)。
- ART组复合鼻部症状总分平均降低2.85,假治疗组降低1.32,组间差异有统计学意义(p=0.027)。
- 以鼻塞亚评分最小临床重要差异0.23判定,ART应答率80.8%,假治疗组46.2%,调整风险比1.95。
核心结论
- ART是治疗鼻塞安全有效的非药物替代方法。
研究设计与样本
- 多中心、随机、双盲、假对照干预研究,共纳入52例成人患者,通过振动头带实施ART或非治疗性假治疗,每日两次、持续2周。
主要发现
- ART组鼻塞亚评分平均变化-0.87(95%CI -1.11, -0.62),假治疗组-0.44(95%CI -0.64, -0.23),p=0.008,ART组较假治疗组改善更大。
- ART组复合鼻部症状总分平均降低2.85(95%CI -3.85, -1.85),假治疗组降低1.32(95%CI -2.27, -0.36),p=0.027,ART组较假治疗组降低更多。
- 以鼻塞亚评分最小临床重要差异0.23判定,ART组应答率80.8%,假治疗组46.2%,调整风险比1.95(95%CI 1.26, 3.02,p=0.003),有利于ART。
- 安全性终点显示无不良事件。
关键数值与推荐
- 鼻塞亚评分最小临床重要差异为0.23。
临床怎么用
- 原文结论认为ART是治疗鼻塞安全有效的非药物替代方法。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Acoustic resonance therapy (ART) is a novel vibrational treatment that delivers patient-specific resonant frequency acoustic energy to the sinonasal cavities. In a pilot study, ART was effective for the acute treatment of nasal congestion. We conducted a sham-controlled randomized trial to validate the efficacy of ART when administered daily for 2 weeks. METHODS: A total of 52 adult patients were enrolled in a multi-center, randomized, double-blinded, sham-controlled, interventional study evaluating ART administered by a vibrational headband. Patients received either active treatment or a non-therapeutic sham treatment twice daily over 2 weeks. Clinical endpoints were the average change in nasal congestion sub-score of the Total Nasal Symptom Score (TNSS) and the average change in composite TNSS. RESULTS: ART resulted in a significantly greater mean change in the nasal congestion sub-score compared to sham (-0.87 [95% confidence interval [CI] -1.11, -0.62] vs. -0.44 [95% CI -0.64, -0.23], p = 0.008). ART also resulted in a significantly greater reduction in the composite TNSS versus sham, (-2.85 [95% CI -3.85, -1.85], vs. -1.32 [95% CI -2.27, -0.36], p = 0.027). The response rate, determined by a nasal congestion sub-score minimal clinically important difference of 0.23, was 80.8% for ART and 46.2% for sham, with an adjusted risk ratio of 1.95 (95% CI 1.26, 3.02, p = 0.003) in favor of ART. Safety endpoints showed no adverse events. CONCLUSION: ART is a safe and effective non-pharmacologic alternative for the treatment of nasal congestion.
引用
- Luong AU, Yong M, Hwang PH, et al. Acoustic resonance therapy is safe and effective for the treatment of nasal congestion in rhinitis: A randomized sham-controlled trial. Int Forum Allergy Rhinol. 2023. PMID: 37812532. doi:10.1002/alr.23284
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。